Lead preclinical program
Buccal Ibogaine
Scientific approach
Buccal delivery + precision formulation.
Ibogaine has an established research history in substance-use disorders and complex pharmacology involving ibogaine and noribogaine exposure. AERASYN's preclinical program is designed to test whether formulation and route can influence absorption, first-pass exposure and dose consistency.
FORMULATION→BUCCAL ROUTE→PK CHARACTERIZATION
Program profile
Current development context.
| Development stage | Preclinical |
| Research context | Substance-use and trauma-associated disorders |
| Delivery route | Buccal |
| Primary evidence needs | PK, bioavailability, safety and tolerability |
| Relevant IP | Therapeutic, delivery and manufacturing |
Our Pipeline